Protein imbalance in the development of skeletal muscle wasting in tumour‐bearing mice
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background: Cancer cachexia occurs in approximately 80% of cancer patients and is a key contributor to cancer‐related death. The mechanisms controlling development of tumour‐induced muscle wasting are not fully elucidated. Specifically, the progression and development of cancer cachexia are underexplored. Therefore, we examined skeletal muscle protein turnover throughout the development of cancer cachexia in tumour‐bearing mice. Methods: Lewis lung carcinoma (LLC) was injected into the hind flank of C57BL6/J mice at 8 weeks age with tumour allowed to develop for 1, 2, 3, or 4 weeks and compared with PBS injected control. Muscle size was measured by cross‐sectional area analysis of haematoxylin and eosin stained tibialis anterior muscle. 2 H 2 O was used to assess protein synthesis throughout the development of cancer cachexia. Immunoblot and RT‐qPCR were used to measure regulators of protein turnover. TUNEL staining was utilized to measure apoptotic nuclei. LLC conditioned media (LCM) treatment of C2C12 myotubes was used to analyse cancer cachexia in vitro. Results: Muscle cross‐sectional area decreased ~40% 4 weeks following tumour implantation. Myogenic signalling was suppressed in tumour‐bearing mice as soon as 1 week following tumour implantation, including lower mRNA contents of Pax7, MyoD, CyclinD1, and Myogenin, when compared with control animals. AchRδ and AchRε mRNA contents were down‐regulated by ~50% 3 weeks following tumour implantation. Mixed fractional synthesis rate protein synthesis was ~40% lower in 4 week tumour‐bearing mice when compared with PBS controls. Protein ubiquitination was elevated by ~50% 4 weeks after tumour implantation. Moreover, there was an increase in autophagy machinery after 4 weeks of tumour growth. Finally, ERK and p38 MAPK phosphorylations were fourfold and threefold greater than control muscle 4 weeks following tumour implantation, respectively. Inhibition of p38 MAPK, but not ERK MAPK, in vitro partially rescued LCM‐induced loss of myotube diameter. Conclusions: Our findings work towards understanding the pathophysiological signalling in skeletal muscle in the initial development of cancer cachexia. Shortly following the onset of the tumour‐bearing state alterations in myogenic regulatory factors are apparent, suggesting early onset alterations in the capacity for myogenic induction. Cancer cachexia presents with a combination of a loss of protein synthesis and increased markers of protein breakdown, specifically in the ubiquitin‐proteasome system. Also, p38 MAPK may be a potential therapeutic target to combat cancer cachexia via a p38‐FOX01‐atrogene‐ubiquitin‐proteasome mechanism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495 · cited 1×
“Prior literature shows that an increased phosphorylation, and corresponding activation, of these MAPKs can lead to both impaired muscle regeneration and increased protein breakdown (45, 46, 66-70).”
BackgroundRegulation mechanisms and signaling pathways of autophagy
He, C., & Klionsky, D. J. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102808-114910 · Cited by 3,609 · cited 3×
“Autophagy is another key controller of protein breakdown (26-28).”
BackgroundSandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012 · cited 1×
“Loss of muscle mass occurs largely from an imbalance of protein turnover favoring protein degradation (47), which is commonly observed in late stage cancer-cachexia (10, 11, 48); however, we are the first to measure modalities of protein turnover throughout a time course of the initial development of LLC-induced cance…”
BackgroundMechanisms regulating skeletal muscle growth and atrophy
Schiaffino, S., Dyar, K. A., Ciciliot, S., Blaauw, B., & Sandri, M. (2013) · The FEBS Journal · doi:10.1111/febs.12253 · Cited by 1,492 · cited 7×
“Furthermore, Atrogin1 mRNA content was threefold greater than PBS control mice 4 weeks after tumour implantation (Figure 4B), whileMuRF1mRNA content was twofold and fourfold greater than PBS control mice at 3 and 4 weeks following tumour implantation (Figure 4B), respectively.”
BackgroundInfluentialNiche Regulation of Muscle Satellite Cell Self-Renewal and Differentiation
Kuang, S., Gillespie, M. A., & Rudnicki, M. A. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2007.12.012 · Cited by 507 · cited 1×
“Our data indicates Pax7 mRNA, a satellite cell marker, content decreased as soon as 1 wk following tumor implantation, implying the satellite cell pool may be diminished thus impairing regenerative capacity shortly after the onset of the tumor-bearing state (51).”
MethodNF-κB–mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia
He, W. A., Berardi, E., Cardillo, V. M., Acharyya, S., Aulino, P., Thomas-Ahner, J., Wang, J., Bloomston, M., Muscarella, P., Nau, P., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68523 · Cited by 357
Bonetto, A., Aydogdu, T., Kunzevitzky, N., Guttridge, D. C., Khuri, S., Koniaris, L. G., & Zimmers, T. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022538 · Cited by 348 · cited 1×
“To this point, other prior studies have examined progression of cancer-cachexia (15, 29), though in most cases focus is placed on varying degrees of cachexia rather than the initial onset of muscle loss.”
Brown, J. L., Rosa‐Caldwell, M. E., Lee, D. E., Blackwell, T. A., Brown, L. A., Perry, R. A., Haynie, W. S., Hardee, J. P., Carson, J. A., Wiggs, M. P., et al. (2017) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12232 · Cited by 288
Self-citationWhite, J. P., Baynes, J. W., Welle, S. L., Kostek, M. C., Matesic, L. E., Sato, S., & Carson, J. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024650 · Cited by 260
Measuring Protein Synthesis With SUnSET: A Valid Alternative to Traditional Techniques?
Goodman, C. A., & Hornberger, T. A. (2013) · Exercise and Sport Sciences Reviews · doi:10.1097/jes.0b013e3182798a95 · Cited by 233 · cited 1×
“Protein synthesis in tissue culture was measured using the SuNSET protocol (41, 42) as we have previously published (37).”
Method
Cited by
Diversity and versatility of p38 kinase signalling in health and disease
Canovas, B., & Nebreda, A. R. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00322-w · Cited by 657
The role and therapeutic potential of stem cells in skeletal muscle in sarcopenia
Cai, Z., Liu, D., Yang, Y., Xie, W., He, M., Yu, D., Wu, Y., Wang, X., Xiao, W., & Li, Y. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02706-5 · Cited by 58
Rosa-Caldwell, M. E., Benson, C. A., Lee, D. E., Brown, J. L., Washington, T. A., Greene, N. P., & Wiggs, M. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217841 · Cited by 13
“specifically measure ventilatory function in the present study, it is plausible to infer that these same detriments to diaphragm health occurred with the onset of cachexia (~3–4 weeks [24,28]).”
BackgroundMethodInfluentialSelf-citationChaillou, T., & Montiel-Rojas, D. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1171850 · Cited by 10
Metadata
- Authors
- Brown, J. L., Lee, D. E., Rosa‐Caldwell, M. E., Brown, L. A., Perry, R. A., Haynie, W. S., Huseman, K., Sataranatarajan, K., Van Remmen, H., Washington, T. A., Wiggs, M. P., & Greene, N. P.
- Venue
- Journal of Cachexia, Sarcopenia and Muscle
- Publisher
- Wiley
- Published
- 2018-10
- Volume
- 9
- Issue
- 5
- Pages
- 987-1002
- ISSN
- 2190-5991 (ISSN-L)
- 2190-6009
- OpenAlex
- W2896057620
- Cited by
- 114
- References
- 12
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Protein imbalance in the development of skeletal muscle wasting in tumour‐bearing mice. https://app.cochat.ai/papers/10.1002/jcsm.12354
- The paper
- Brown, J. L., Lee, D. E., Rosa‐Caldwell, M. E., Brown, L. A., Perry, R. A., Haynie, W. S., Huseman, K., Sataranatarajan, K., Van Remmen, H., Washington, T. A., Wiggs, M. P., & Greene, N. P. (2018). Protein imbalance in the development of skeletal muscle wasting in tumour‐bearing mice. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.12354
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.